Heron Therapeutics, Inc.
Pembelian
Diupdate

HRTX - Biotech long play

202
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.


Investment Snapshot (As of May 31, 2024):
Shares in Circulation: 116.291M
Short Float: 26.03%

Recent Activity:

Blockbuy
Active Stake
Heron Therapeutics Submits ZYNRELEF® Supplement to FDA

Key Technical Levels:
Breakout Zone: $3.70 - $4.00.

Note: A slight pullback to the $3.50 area is possible before moving higher.

Resistance Points:

$4.00
$4.50

Surpassing these levels could signal a positive trend. Consider taking profits at these stages to realize gains.

Trading Strategy:

Take Profit (TP): Target $4.50 or even $5.50 to capitalize on the anticipated price gap closure.

Stop Loss (SL): Set at under $3.15 to mitigate potential losses.

Chart Analysis:
Please refer to the attached chart for detailed analysis of price trends and movements.

Trading Advisory:
Exercise caution and consider market conditions and your own risk tolerance when trading. It's advisable to conduct comprehensive research or consult with a financial advisor before engaging in trading activities.

Disclaimer: This content is for informational purposes only and should not be considered financial advice.
Trading ditutup: stop tercapai
Catatan
Friday June 28, 2024
04:19:32PM
HRTX
Block Trade: HRTX 795,477 @ $3.50 at the ask
Signals
04:09:39PM
HRTX
Block Trade: HRTX 874,033 @ $3.50

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.